Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
Go back to Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026| (NASDAQ: KRYS) | Delayed: 337.37 -1.38 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $338.75 | 52 Week High | $ | |||
| Open | $340.00 | 52 Week Low | $ | |||
| Day High | $341.35 | P/E | N/A | |||
| Day Low | $335.50 | EPS | $ | |||
| Volume | 107,041 | |||||

